Bristol-Myers Squibb is set to buy peer Celgene in a cash-and-stock deal that will bring together two healthcare corporate venturing portfolios.

HTGF, Think.Health Ventures and Business Angels have also supplied funding to Max Planck Institute for Biochemistry mass spectrometry spinout PreOmics.

Boston Scientific has exercised its option to wholly acquire Millipede, based on research at Michigan, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.

Boston Scientific has exercised its option to wholly acquire Millipede, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.

The series A capital will support construction of a cellular production plant in China for the pharmaceutical services provider.

Martin Bauer's PRM Holdings unit has contributed to a round that will help Syqe expand use of its medical cannabis inhaler to other substances.

UC Berkeley spinout Iota Biosciences has obtained $15m in series A capital from investors including Astellas.

Astellas chipped in as UC Berkeley spinout Iota Biosciences captured $15m in a series A round that will fund the entry of its neural dust technology into preclinical testing.

Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.

The blood-testing device producer, which counts Access Industries and Haisco as investors, has added $28m to its coffers.